Operating Leases Operating Leased Assets [Line Items] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Pay vs Performance Disclosure [Line Items] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Research and development Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Effect of foreign currency on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Deferred tax liabilities Deferred Income Tax Liabilities, Net MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Accounts payable Accounts Payable, Current Restatement Determination Date: Restatement Determination Date [Axis] Commitments and contingencies Commitments and Contingencies Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Stockholders' Equity Equity [Text Block] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Other assets Increase (Decrease) in Other Noncurrent Assets Income Taxes Income Tax Disclosure [Text Block] Restricted cash Restricted cash Restricted Cash and Cash Equivalents, Noncurrent Customer [Axis] Customer [Axis] Current liabilities: Liabilities, Current [Abstract] Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of June 30, 2023 and December 31, 2022 Preferred Stock, Value, Issued Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Net loss per common share, diluted (in USD per share) Earnings Per Share, Diluted Short-term investments, allowance for expected credit losses Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest PEO Total Compensation Amount PEO Total Compensation Amount HalioDx customer relationships HalioDx Customer Relationships [Member] HalioDx Customer Relationships Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Options issued and outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Net loss Net loss Net loss Net Income (Loss) Total current liabilities Liabilities, Current Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Employee stock purchase plan Employee Stock [Member] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Deferred revenue Contract with Customer, Liability Executive Category: Executive Category [Axis] LymphMark product technology LymphMark Product Technology [Member] Represents LymphMark product technology. Name Measure Name Name Forgone Recovery, Individual Name Goodwill Goodwill Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Shares available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Stock-based compensation expense (non-employee) Adjustments To Additional Paid In Capital, Share Based Compensation, Non Employee Amount of increase In additional paid-in capital (APIC) resulting from non-employee stock-based compensation expense. Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Stock-based compensation expense (employee) Adjustments To Additional Paid In Capital, Share Based Compensation, Employee Amount of increase in additional paid-in capital (APIC) resulting from employee stock-based compensation expense. Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Accounts receivable Accounts Receivable [Member] Operating lease liabilities, net of current portion Long-term lease liabilities Operating Lease, Liability, Noncurrent Restricted stock units Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Percepta product technology Percepta Product Technology [Member] Percepta Technology [Member] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Tax portion of vested restricted stock units Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of Outstanding Common Stock Equivalents Excluded From Diluted Net Loss Per Common Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Schedule of Operating Lease Expense and Measurement Of Lease Liabilities Lease, Cost [Table Text Block] Supplies and inventory Increase (Decrease) in Inventories Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Award Type [Axis] Award Type [Axis] Common stock equivalents (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Defined Benefit Plan, Type [Extensible List] Defined Benefit Plan, Type [Extensible Enumeration] Document Quarterly Report Document Quarterly Report Purchases of property, plant and equipment included in accounts payable and accrued liability Capital Expenditures Incurred but Not yet Paid 2023 remainder of year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Trading Arrangement: Trading Arrangement [Axis] Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Use of Estimates Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Discount rate Measurement Input, Discount Rate [Member] Current portion of operating lease liabilities Less: short-term lease liabilities Operating Lease, Liability, Current HalioDx customer backlog HalioDx Customer Backlog [Member] HalioDx Customer Backlog Issuance of common stock under employee stock purchase plan (ESPP) (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Intangible asset amortization Amortization of Intangible Assets Entity Shell Company Entity Shell Company 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Total Finite-Lived Intangible Assets, Net Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date French research tax credits Other Nonoperating Income (Expense), Foreign Tax Credit Foreign Tax Credit, Nonoperating Term of lease Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Reserved Shares of Common Stock for Issuance Schedule of Stock by Class [Table Text Block] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Common stock, shares issued (in shares) Common Stock, Shares, Issued Other Other Nonoperating Income (Expense), Other Other Nonoperating Income (Expense), Other Cash paid in acquisition Business Combination, Consideration Transferred Current portion of deferred revenue Contract with Customer, Liability, Current Security Exchange Name Security Exchange Name Pension Liability Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block] Decipher product technology Decipher BioSciences Product Technology [Member] Decipher BioSciences Product Technology Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Employee Stock Option Employee Stock Option [Member] Short-Term Investments Investment, Policy [Policy Text Block] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Organization, Description of Business and Summary of Significant Accounting Policies Business Description and Accounting Policies [Text Block] Total operating expenses Costs and Expenses Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Maximum Maximum [Member] Net comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document Type Document Type Tabular List, Table Tabular List [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two nCounter Dx license nCounter Dx License [Member] nCounter Dx License [Member] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Interest on end-of-term debt obligation Debt Instrument, End Of Term Payment Interest Amount And Prepayment Penalty Debt Instrument, End Of Term Payment Interest Amount And Prepayment Penalty Gain (loss) on currency revaluation Other Nonoperating Income (Expense), Foreign Currency Translation Gain (Loss) Foreign Currency Translation Gain (Loss), Nonoperating Business Acquisition [Axis] Business Acquisition [Axis] Customer concentration risk Customer Concentration Risk [Member] Current portion of other liabilities Other Liabilities, Current Prosigna customer relationships Prosigna Customer Relationships [Member] Represents Prosigna customer relationships. Income Statement [Abstract] Income Statement [Abstract] Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Probability of achievement Measurement Input, Probability Of Achievement [Member] Measurement input using probability of achievement. Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Class of Stock [Line Items] Class of Stock [Line Items] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Entity Tax Identification Number Entity Tax Identification Number Supplies and inventory Inventory, Net Proceeds from sale of short-term investments Proceeds from Sale of Held-to-Maturity Securities Raw materials and finished diagnostic kits Inventory, Work in Process and Raw Materials Medicare Medicare [Member] Represents Medicare. Statistical Measurement [Axis] Statistical Measurement [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Issuance of common stock on exercise of stock options and vesting of restricted stock units Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Total Shareholder Return Amount Total Shareholder Return Amount Product revenue Product [Member] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Schedule of Other Income, net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Proceeds from maturity of short-term investments Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities Accumulated deficit Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Revenue Recognition and Cost of Revenue Revenue from Contract with Customer [Policy Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Deposits Deposits for leases Security Deposit Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Outstanding shares of common stock equivalents that have been excluded from diluted net loss per common share Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Other Income and Expenses [Abstract] PEO PEO [Member] Balance at beginning of period (in shares) Balance at end of period (in shares) Shares, Outstanding Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Interest expense Other Nonoperating Income (Expense), Interest Expense Interest Expense, Nonoperating Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Present value of future lease payments Operating Lease, Liability Measurement Input Type [Domain] Measurement Input Type [Domain] Total liabilities Liabilities Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Balance Sheet Related Disclosures [Abstract] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Total number of shares reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance All Executive Categories All Executive Categories [Member] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Annual rent Lessee, Operating Lease, Lease Not Yet Commenced, Annual Undiscounted Amount Lessee, Operating Lease, Lease Not Yet Commenced, Annual Undiscounted Amount Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Earnings Per Share [Abstract] Selling and marketing Selling and Marketing Expense Common stock, $0.001 par value; 125,000,000 shares authorized, 72,643,156 and 71,959,454 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Contingent consideration, changes in fair value Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Business Combination, Contingent Consideration, Liability, Fair Value Adjustment General and administrative General and Administrative Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total current assets Assets, Current Impairment loss Asset Impairment Charges Schedule of Third-party Payers as a Percentage of Total Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Acquisition-related contingent consideration, net of current portion Business Combination, Contingent Consideration, Liability All Individuals All Individuals [Member] Supplementary cash flow information: Supplemental Cash Flow Information [Abstract] Contract manufacturing and testing Biopharmaceutical And Other - Contract Manufacturing And Testing [Member] Biopharmaceutical And Other - Contract Manufacturing And Testing Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other income (loss), net Other income (loss), net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Purchase of short-term investments Payments to Acquire Held-to-Maturity Securities Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Short-term investments, fair value Debt Securities, Held-to-Maturity, Fair Value PEO Name PEO Name Concentration risk Concentration Risk, Percentage Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Components of Other Income Other Nonoperating Income and Expense [Text Block] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Biopharmaceutical and other revenue Biopharmaceutical And Other [Member] Represents biopharmaceutical. Schedule of Future Aggregate Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Current portion of acquisition-related contingent consideration Short term contingent considerations Business Combination, Contingent Consideration, Liability, Current Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accrued other Other Accrued Liabilities, Current Depreciation and amortization Depreciation, Depletion and Amortization Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total stockholders’ equity Balance at beginning of period Balance at end of period Equity, Attributable to Parent Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Change in currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Entity Emerging Growth Company Entity Emerging Growth Company Concentrations of Credit Risk and Other Risks and Uncertainties Concentrations Of Credit And Other Risks And Uncertainties [Policy Text Block] Disclosure of accounting policy for concentrations of credit risk and other risks and uncertainties. Noncash lease expense Noncash Lease Expense The noncash portion of lease expense. Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Lab supplies and reagents consumed Inventory, Finished Goods, Gross Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Weighted Average Remaining Amortization Period (Years) Finite-Lived Intangible Asset, Useful Life Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Title Trading Arrangement, Individual Title Operating lease expense Operating Lease, Expense Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Weighted Average Weighted Average [Member] Common Stock Common Stock [Member] Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Accrued liabilities and deferred revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Net Loss Per Common Share Earnings Per Share [Text Block] Product and Service [Axis] Product and Service [Axis] Finance Lease, Liability, Statement of Financial Position [Extensible List] Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] Document Fiscal Year Focus Document Fiscal Year Focus Minimum Minimum [Member] HalioDx developed technology HalioDX Developed Technology [Member] HalioDX Developed Technology Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Pension obligation Defined Benefit Plan, Benefit Obligation Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Thereafter Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Effect of foreign currency on operations Gain (Loss), Foreign Currency Transaction, before Tax Operating lease liabilities Increase (Decrease) in Operating Lease Liability Payment of taxes on vested restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Shares of common stock subject to outstanding options Employee And Non Employee Stock Option [Member] An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, number of shares in the entity at a specified price, as defined in the agreement. Accumulated Deficit Retained Earnings [Member] Customers Representing >10% Of Total Revenue Major Customers [Member] Major Customers Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net loss per common share, basic (in USD per share) Earnings Per Share, Basic Right-of-use assets, operating leases Operating Lease, Right-of-Use Asset Issuance of common stock under employee stock purchase plan (ESPP) Stock Issued During Period, Value, Employee Stock Purchase Plan Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Remainder of 2023 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Equity Interest Issued or Issuable, Type [Domain] Equity Interest Issued or Issuable, Type [Domain] Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Cash paid for tax Income Taxes Paid Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Short-term investments Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss Termination Date Trading Arrangement Termination Date Accounts payable Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] Measurement Input Type [Axis] Measurement Input Type [Axis] All Adjustments to Compensation All Adjustments to Compensation [Member] Award Timing Disclosures [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Interest income Other Nonoperating Income (Expense), Interest Income Other Nonoperating Income (Expense), Interest Income Deferred income taxes Deferred Income Tax Expense (Benefit) Proceeds from the exercise of common stock options and employee stock purchases Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Finance lease liabilities Finance Lease, Liability Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Insider Trading Arrangements [Line Items] Schedule of Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Additional cash to be paid Business Combination, Contingent Consideration, Cash To Be Paid Business Combination, Contingent Consideration, Cash To Be Paid Stock-based compensation expense (ESPP) Adjustments To Additional Paid In Capital, Share Based Compensation, ESPP Amount of increase in additional paid-in capital (APIC) resulting from ESPP stock-based compensation expense. Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Adjustment to Compensation, Amount Adjustment to Compensation Amount Decipher trade names Decipher Biosciences Trade Names [Member] Decipher Biosciences Trade Names Revaluation of acquisition-related contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Revenue Revenue from Contract with Customer Benchmark [Member] Realized gains (losses) from sale of short-term investments Debt Security, Held-to-Maturity, Sold, Realized Gain (Loss) Payment of long-term debt Repayments of Long-Term Debt Entity Central Index Key Entity Central Index Key Loss on disposal of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Income tax expense (benefit) Income tax expense (benefit) Income Tax Expense (Benefit) Finance right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Accrued compensation expenses Employee-related Liabilities, Current Fair Value Measurements Fair Value Disclosures [Text Block] Number of operating segments Number of Operating Segments Name Trading Arrangement, Individual Name Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Revenue Disaggregation of Revenue [Table Text Block] Equity [Abstract] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Amendment Flag Amendment Flag NanoString NanoString [Member] Represents NanoString. Money Market Funds Money Market Funds [Member] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Discount rate Operating Lease, Weighted Average Discount Rate, Percent Testing revenue Testing [Member] Represents testing. Equity Interest Type [Axis] Equity Interest Type [Axis] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Shares used to compute net loss per common share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Facilities in Marseille, France Facilities In Marseille, France [Member] Facilities In Marseille, France Amortized cost of short-term investments sold Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Sold, Amount Operating expenses: Operating Expenses [Abstract] Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid-in Capital Additional Paid-in Capital [Member] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Cover [Abstract] Cover [Abstract] Other liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Value of shares issued in acquisition Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Shares used to compute net loss per common share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Loss from operations Operating Income (Loss) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Revenue: Revenues [Abstract] Cost of revenue Cost of Revenue Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Statement [Line Items] Statement [Line Items] Prosigna product technology Developed Product Technology [Member] Developed Product Technology Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] UnitedHealthcare United Healthcare [Member] Represents United Healthcare. Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Biopharmaceutical revenue Biopharmaceutical And Other - Biopharmaceutical Revenue [Member] Biopharmaceutical And Other - Biopharmaceutical Revenue Sale of short-term investments Debt Securities, Held-to-Maturity, Sold at Par Value Pension Plan [Member]